New Zealand markets close in 1 hour 17 minutes

Senti Biosciences, Inc. (SNTI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3700+0.0013 (+0.35%)
At close: 04:00PM EDT
0.3805 +0.01 (+2.84%)
After hours: 06:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.93M
Enterprise value 18.67M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.30
Price/book (mrq)0.25
Enterprise value/revenue 9.44
Enterprise value/EBITDA -0.30

Trading information

Stock price history

Beta (5Y monthly) 2.97
52-week change 3-65.19%
S&P500 52-week change 322.38%
52-week high 31.1000
52-week low 30.2700
50-day moving average 30.3724
200-day moving average 30.4780

Share statistics

Avg vol (3-month) 3118.9k
Avg vol (10-day) 3301.08k
Shares outstanding 545.76M
Implied shares outstanding 645.76M
Float 828.11M
% held by insiders 122.40%
% held by institutions 124.30%
Shares short (15 Apr 2024) 4165.24k
Short ratio (15 Apr 2024) 41.9
Short % of float (15 Apr 2024) 40.54%
Short % of shares outstanding (15 Apr 2024) 40.36%
Shares short (prior month 15 Mar 2024) 4223.18k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,516.28%

Management effectiveness

Return on assets (ttm)-26.83%
Return on equity (ttm)-85.91%

Income statement

Revenue (ttm)2.56M
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -60.88M
Net income avi to common (ttm)-83.41M
Diluted EPS (ttm)-1.8800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)35.97M
Total cash per share (mrq)0.79
Total debt (mrq)37.67M
Total debt/equity (mrq)56.29%
Current ratio (mrq)5.62
Book value per share (mrq)1.46

Cash flow statement

Operating cash flow (ttm)-52.4M
Levered free cash flow (ttm)-75.14M